Stanley Holstein
Neurology · New Rochelle, NYNPI 1720148869
Payments from drug & device makers
Across 98 payments — averaging $33.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$637
- Teva Pharmaceuticals USA, Inc.$338
- Novartis$292
- EMD Serono, Inc.$282
- Acorda Therapeutics, Inc$231
- Lilly USA, LLC$179
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$672%
- Food & beverage$3,26198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $637 |
| Teva Pharmaceuticals USA, Inc. | 3 | $338 |
| Novartis | 14 | $292 |
| EMD Serono, Inc. | 6 | $282 |
| Acorda Therapeutics, Inc | 8 | $231 |
| Lilly USA, LLC | 3 | $179 |
| Sunovion Pharmaceuticals Inc. | 8 | $155 |
| Genentech USA, Inc. | 2 | $154 |
| Biogen | 3 | $131 |
| Adamas Pharmaceuticals, Inc. | 6 | $129 |
| Akcea Therapeutics, Inc. | 1 | $117 |
| Johnson & Johnson | 4 | $93 |
| Lundbeck LLC | 2 | $88 |
| AbbVie | 5 | $86 |
| Avion Pharmaceuticals | 3 | $68 |
| Kyowa Kirin, Inc. | 2 | $57 |
| Amgen | 2 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| PTC Therapeutics, Inc. | 2 | $40 |
| Pfizer | 2 | $40 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| NS Pharma, Inc. | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,328 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 12 | $308 |
| Gabapentin | 30 | $237 |
| Baclofen | 14 | $183 |
| Cyclobenzaprine Hcl | 42 | $153 |
| Donepezil Hcl | 21 | $142 |
| Meclizine Hcl | 14 | $112 |
| Topiramate | 28 | $108 |
| Memantine Hcl | 12 | $102 |
| Ibuprofen | 27 | $64 |
| Zolpidem Tartrate | 15 | $50 |
| Quetiapine Fumarate | 11 | $40 |
| Meloxicam | 18 | $28 |
Paid to pharmacies, not to this prescriber.
Other neurology in New Rochelle
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
- Krupa PandeyAlbany$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.